ISSN:

Journal Home

Journal Guideline

Cancer Treatment and Research Communications Q2 Unclaimed

Elsevier Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Treatment and Research Communications is a journal indexed in SJR in Oncology and Cancer Research with an H index of 29. It has an SJR impact factor of 0,971 and it has a best quartile of Q2. It has an SJR impact factor of 0,971.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Cancer Treatment and Research Communications

0,971

SJR Impact factor

29

H Index

99

Total Docs (Last Year)

486

Total Docs (3 years)

4879

Total Refs

1440

Total Cites (3 years)

476

Citable Docs (3 years)

2.49

Cites/Doc (2 years)

49.28

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
Cancer Cytopathology Q2
Cancer Causes & Control Q2
BMC Cancer Q2
Current Opinion in Oncology Q2

Compare this journals